Mo Mandegar is a senior scientist at Tenaya Therapeutics in San Francisco, California. At Tenaya, Mo has led drug discovery efforts using stem cell technology and phenotypic screening powered by artificial intelligence. His research efforts have resulted in the establishment of a pre-clinical program at Tenaya where the lead molecule is under the final stages of drug development.